LF
GSK icon

LifeSteps Financial’s GSK GSK Stock Holding History

LifeSteps Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.91K Buy
+170
New +$8.99K ﹤0.01% 436

Other funds holding GSK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LifeSteps Financial's GSK Position: Q2 2026 in Review

LifeSteps Financial opened a new position in GSK (GSK) in Q2 2026: 170 shares worth $8.91K. The stake represents ﹤0.01% of the portfolio and ranks #436 among its holdings.

416 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • LifeSteps Financial held 170 shares of GSK worth $8.91K as of Q2 2026.
  • GSK was a new LifeSteps Financial position in Q2 2026.
  • GSK made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #436 holding.
  • 416 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.